Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Forschner

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Clinics in Dermatology|April 24, 2013
The role of radiotherapy in the overall treatment of melanomaAndrea Forschner, Vanessa Heinrich, Annette Pflugfelder, et al.
International Journal of Cancer|March 8, 2026
Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanomaPatrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, et al.
Cancers|June 2, 2021
Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective StudyLisa Wiens, Norbert Schäffeler, Thomas Eigentler, et al.
Frontiers in Oncology|December 15, 2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanomaCharlotte Nübel, Teresa Amaral, Ulrike Leiter, et al.
British Journal of Cancer|June 29, 2018
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodiesNikolaus B Wagner, Andrea Forschner, Ulrike Leiter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2023
Prognosis in stage II melanoma of the head and neck depends on the histological subtypeSophie Jasper, Ulrike Keim, Ulrike Leiter, et al.
Dermatology (Basel, Switzerland)|June 17, 2020
Dermatofluoroscopy Is Also for Redheads a Sensitive Method of Early Melanoma DetectionDieter Leupold, Lukasz Szyc, Goran Stankovic, et al.
JAMA Dermatology|May 17, 2013
Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasisAndrea Forschner, Heike Niessner, Juergen Bauer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Die Prognose des Melanoms im Kopf-Hals-Bereich im Stadium II hängt vom histologischen Subtyp abSophie Jasper, Ulrike Keim, Ulrike Leiter, et al.
International Journal of Molecular Sciences|June 2, 2021
From Melanocytes to Melanoma Cells: Characterization of the Malignant Transformation by Four Distinctly Different Melanin Fluorescence Spectra (Review)Dieter Leupold, Lutz Pfeifer, Maja Hofmann, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Clinics in Dermatology|April 24, 2013
The role of radiotherapy in the overall treatment of melanomaAndrea Forschner, Vanessa Heinrich, Annette Pflugfelder, et al.
International Journal of Cancer|March 8, 2026
Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanomaPatrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, et al.
Cancers|June 2, 2021
Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective StudyLisa Wiens, Norbert Schäffeler, Thomas Eigentler, et al.
Frontiers in Oncology|December 15, 2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanomaCharlotte Nübel, Teresa Amaral, Ulrike Leiter, et al.
British Journal of Cancer|June 29, 2018
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodiesNikolaus B Wagner, Andrea Forschner, Ulrike Leiter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2023
Prognosis in stage II melanoma of the head and neck depends on the histological subtypeSophie Jasper, Ulrike Keim, Ulrike Leiter, et al.
Dermatology (Basel, Switzerland)|June 17, 2020
Dermatofluoroscopy Is Also for Redheads a Sensitive Method of Early Melanoma DetectionDieter Leupold, Lukasz Szyc, Goran Stankovic, et al.
JAMA Dermatology|May 17, 2013
Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasisAndrea Forschner, Heike Niessner, Juergen Bauer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Die Prognose des Melanoms im Kopf-Hals-Bereich im Stadium II hängt vom histologischen Subtyp abSophie Jasper, Ulrike Keim, Ulrike Leiter, et al.
International Journal of Molecular Sciences|June 2, 2021
From Melanocytes to Melanoma Cells: Characterization of the Malignant Transformation by Four Distinctly Different Melanin Fluorescence Spectra (Review)Dieter Leupold, Lutz Pfeifer, Maja Hofmann, et al.
Pageof 16